Myotubular Myopathy in a Girl with a Deletion at Xq27-q28 and Unbalanced X Inactivation Assigns the MTMI Gene to a 600-kb Region (original) (raw)

. 1995 May;56(5):1108–1115.

Abstract

A young girl with a clinically moderate form of myotubular myopathy was found to carry a cytogenetically detectable deletion in Xq27-q28. The deletion had occurred de novo on the paternal X chromosome. It encompasses the fragile X (FRAXA) and Hunter syndrome (IDS) loci, and the DXS304 and DXS455 markers, in Xq27.3 and proximal Xq28. Other loci from the proximal half of Xq28 (DXS49, DXS256, DXS258, DXS305, and DXS497) were found intact. As the X-linked myotubular myopathy locus (MTM1) was previously mapped to Xq28 by linkage analysis, the present observation suggested that MTM1 is included in the deletion. However, a significant clinical phenotype is unexpected in a female MTM1 carrier. Analysis of inactive X-specific methylation at the androgen receptor gene showed that the deleted X chromosome was active in ∼80% of leukocytes. Such unbalanced inactivation may account for the moderate MTM1 phenotype and for the mental retardation that later developed in the patient. This observation is discussed in relation to the hypothesis that a locus modulating X inactivation may lie in the region. Comparison of this deletion with that carried by a male patient with a severe Hunter syndrome phenotype but no myotubular myopathy, in light of recent linkage data on recombinant MTM1 families, led to a considerable refinement of the position of the MTM1 locus, to a region of ∼600 kb, between DXS304 and DXS497.

1108

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen R. C., Zoghbi H. Y., Moseley A. B., Rosenblatt H. M., Belmont J. W. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992 Dec;51(6):1229–1239. [PMC free article] [PubMed] [Google Scholar]
  2. Askanas V., Engel W. K., Reddy N. B., Barth P. G., Bethlem J., Krauss D. R., Hibberd M. E., Lawrence J. V., Carter L. S. X-linked recessive congenital muscle fiber hypotrophy with central nuclei: abnormalities of growth and adenylate cyclase in muscle tissue cultures. Arch Neurol. 1979 Oct;36(10):604–609. doi: 10.1001/archneur.1979.00500460038003. [DOI] [PubMed] [Google Scholar]
  3. Beck M., Steglich C., Zabel B., Dahl N., Schwinger E., Hopwood J. J., Gal A. Deletion of the Hunter gene and both DXS466 and DXS304 in a patient with mucopolysaccharidosis type II. Am J Med Genet. 1992 Sep 1;44(1):100–103. doi: 10.1002/ajmg.1320440123. [DOI] [PubMed] [Google Scholar]
  4. Boyd Y., Fraser N. J. Methylation patterns at the hypervariable X-chromosome locus DXS255 (M27 beta): correlation with X-inactivation status. Genomics. 1990 Jun;7(2):182–187. doi: 10.1016/0888-7543(90)90539-7. [DOI] [PubMed] [Google Scholar]
  5. Broadhead D. M., Kirk J. M., Burt A. J., Gupta V., Ellis P. M., Besley G. T. Full expression of Hunter's disease in a female with an X-chromosome deletion leading to non-random inactivation. Clin Genet. 1986 Nov;30(5):392–398. doi: 10.1111/j.1399-0004.1986.tb01896.x. [DOI] [PubMed] [Google Scholar]
  6. Clarke J. T., Greer W. L., Strasberg P. M., Pearce R. D., Skomorowski M. A., Ray P. N. Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl. Am J Hum Genet. 1991 Aug;49(2):289–297. [PMC free article] [PubMed] [Google Scholar]
  7. Clarke J. T., Wilson P. J., Morris C. P., Hopwood J. J., Richards R. I., Sutherland G. R., Ray P. N. Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome. Am J Hum Genet. 1992 Aug;51(2):316–322. [PMC free article] [PubMed] [Google Scholar]
  8. Consalez G. G., Stayton C. L., Freimer N. B., Goonewardena P., Brown W. T., Gilliam T. C., Warren S. T. Isolation and characterization of a highly polymorphic human locus (DXS455) in proximal Xq28. Genomics. 1992 Apr;12(4):710–714. doi: 10.1016/0888-7543(92)90299-8. [DOI] [PubMed] [Google Scholar]
  9. Dahl N., Goonewardena P., Malmgren H., Gustavson K. H., Holmgren G., Seemanova E., Annerén G., Flood A., Pettersson U. Linkage analysis of families with fragile-X mental retardation, using a novel RFLP marker (DXS 304). Am J Hum Genet. 1989 Aug;45(2):304–309. [PMC free article] [PubMed] [Google Scholar]
  10. Dahl N., Samson F., Thomas N. S., Hu L. J., Gong W., Herman G., Laporte J., Kioschis P., Poustka A., Mandel J. L. X linked myotubular myopathy (MTM1) maps between DXS304 and DXS305, closely linked to the DXS455 VNTR and a new, highly informative microsatellite marker (DXS1684). J Med Genet. 1994 Dec;31(12):922–924. doi: 10.1136/jmg.31.12.922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Darnfors C., Larsson H. E., Oldfors A., Kyllerman M., Gustavson K. H., Bjursell G., Wahlström J. X-linked myotubular myopathy: a linkage study. Clin Genet. 1990 May;37(5):335–340. doi: 10.1111/j.1399-0004.1990.tb03515.x. [DOI] [PubMed] [Google Scholar]
  12. Fuscoe J. C., Fenwick R. G., Jr, Ledbetter D. H., Caskey C. T. Deletion and amplification of the HGPRT locus in Chinese hamster cells. Mol Cell Biol. 1983 Jun;3(6):1086–1096. doi: 10.1128/mcb.3.6.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gedeon A. K., Baker E., Robinson H., Partington M. W., Gross B., Manca A., Korn B., Poustka A., Yu S., Sutherland G. R. Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet. 1992 Aug;1(5):341–344. doi: 10.1038/ng0892-341. [DOI] [PubMed] [Google Scholar]
  14. Gilgenkrantz S., Briquel M. E., Mandel J. L., Oberle I. A case of female hemophilia with a 46,XXr karyotype studied with X-chromosome DNA probes. Hum Genet. 1986 Feb;72(2):157–159. doi: 10.1007/BF00283936. [DOI] [PubMed] [Google Scholar]
  15. Hall C. W., Liebaers I., Di Natale P., Neufeld E. F. Enzymic diagnosis of the genetic mucopolysaccharide storage disorders. Methods Enzymol. 1978;50:439–456. doi: 10.1016/0076-6879(78)50048-7. [DOI] [PubMed] [Google Scholar]
  16. Hirst M. C., Roche A., Flint T. J., MacKinnon R. N., Bassett J. H., Nakahori Y., Watson J. E., Bell M. V., Patterson M. N., Boyd Y. Linear order of new and established DNA markers around the fragile site at Xq27.3. Genomics. 1991 May;10(1):243–249. doi: 10.1016/0888-7543(91)90506-a. [DOI] [PubMed] [Google Scholar]
  17. Lehesjoki A. E., Sankila E. M., Miao J., Somer M., Salonen R., Rapola J., de la Chapelle A. X linked neonatal myotubular myopathy: one recombination detected with four polymorphic DNA markers from Xq28. J Med Genet. 1990 May;27(5):288–291. doi: 10.1136/jmg.27.5.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Migeon B. R. The postulated X-inactivation center at Xq27 is most reasonably explained by ascertainment bias: heterozygous expression of recessive mutations is a powerful means of detecting unbalanced X inactivation. Am J Hum Genet. 1993 Feb;52(2):431–434. [PMC free article] [PubMed] [Google Scholar]
  19. Nisen P., Stamberg J., Ehrenpreis R., Velasco S., Shende A., Engelberg J., Karayalcin G., Waber L. The molecular basis of severe hemophilia B in a girl. N Engl J Med. 1986 Oct 30;315(18):1139–1142. doi: 10.1056/NEJM198610303151806. [DOI] [PubMed] [Google Scholar]
  20. Oberlé I., Camerino G., Kloepfer C., Moisan J. P., Grzeschik K. H., Hellkuhl B., Hors-Cayla M. C., Van Cong N., Weil D., Mandel J. L. Characterization of a set of X-linked sequences and of a panel of somatic cell hybrids useful for the regional mapping of the human X chromosome. Hum Genet. 1986 Jan;72(1):43–49. doi: 10.1007/BF00278816. [DOI] [PubMed] [Google Scholar]
  21. Palmieri G., Romano G., Casamassimi A., D'Urso M., Little R. D., Abidi F. E., Schlessinger D., Lagerström M., Malmgren H., Steen-Bondeson M. L. 1.5-Mb YAC contig in Xq28 formatted with sequence-tagged sites and including a region unstable in the clones. Genomics. 1993 Jun;16(3):586–592. doi: 10.1006/geno.1993.1234. [DOI] [PubMed] [Google Scholar]
  22. Palmieri G., Romano G., Ciccodicola A., Casamassimi A., Campanile C., Esposito T., Cappa V., Lania A., Johnson S., Reinbold R. YAC contig organization and CpG island analysis in Xq28. Genomics. 1994 Nov 1;24(1):149–158. doi: 10.1006/geno.1994.1592. [DOI] [PubMed] [Google Scholar]
  23. Poustka A., Dietrich A., Langenstein G., Toniolo D., Warren S. T., Lehrach H. Physical map of human Xq27-qter: localizing the region of the fragile X mutation. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8302–8306. doi: 10.1073/pnas.88.19.8302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Richards R. I., Holman K., Kozman H., Kremer E., Lynch M., Pritchard M., Yu S., Mulley J., Sutherland G. R. Fragile X syndrome: genetic localisation by linkage mapping of two microsatellite repeats FRAXAC1 and FRAXAC2 which immediately flank the fragile site. J Med Genet. 1991 Dec;28(12):818–823. doi: 10.1136/jmg.28.12.818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rogner U. C., Kioschis P., Wilke K., Gong W., Pick E., Dietrich A., Zechner U., Hameister H., Pragliola A., Herman G. E. A YAC clone map spanning 7.5 megabases of human chromosome band Xq28. Hum Mol Genet. 1994 Dec;3(12):2137–2146. doi: 10.1093/hmg/3.12.2137. [DOI] [PubMed] [Google Scholar]
  26. Rousseau F., Heitz D., Biancalana V., Blumenfeld S., Kretz C., Boué J., Tommerup N., Van Der Hagen C., DeLozier-Blanchet C., Croquette M. F. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med. 1991 Dec 12;325(24):1673–1681. doi: 10.1056/NEJM199112123252401. [DOI] [PubMed] [Google Scholar]
  27. Rousseau F., Heitz D., Oberlé I., Mandel J. L. Selection in blood cells from female carriers of the fragile X syndrome: inverse correlation between age and proportion of active X chromosomes carrying the full mutation. J Med Genet. 1991 Dec;28(12):830–836. doi: 10.1136/jmg.28.12.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sarnat H. B. Vimentin and desmin in maturing skeletal muscle and developmental myopathies. Neurology. 1992 Aug;42(8):1616–1624. doi: 10.1212/wnl.42.8.1616. [DOI] [PubMed] [Google Scholar]
  29. Schmidt M., Certoma A., Du Sart D., Kalitsis P., Leversha M., Fowler K., Sheffield L., Jack I., Danks D. M. Unusual X chromosome inactivation in a mentally retarded girl with an interstitial deletion Xq27: implications for the fragile X syndrome. Hum Genet. 1990 Mar;84(4):347–352. doi: 10.1007/BF00196232. [DOI] [PubMed] [Google Scholar]
  30. Schmidt M. Do sequences in Xq27.3 play a role in X inactivation? 1992 Apr 15-May 1Am J Med Genet. 43(1-2):279–281. doi: 10.1002/ajmg.1320430143. [DOI] [PubMed] [Google Scholar]
  31. Starr J., Lamont M., Iselius L., Harvey J., Heckmatt J. A linkage study of a large pedigree with X linked centronuclear myopathy. J Med Genet. 1990 May;27(5):281–283. doi: 10.1136/jmg.27.5.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tarleton J., Richie R., Schwartz C., Rao K., Aylsworth A. S., Lachiewicz A. An extensive de novo deletion removing FMR1 in a patient with mental retardation and the fragile X syndrome phenotype. Hum Mol Genet. 1993 Nov;2(11):1973–1974. doi: 10.1093/hmg/2.11.1973. [DOI] [PubMed] [Google Scholar]
  33. Thomas N. S., Williams H., Cole G., Roberts K., Clarke A., Liechti-Gallati S., Braga S., Gerber A., Meier C., Moser H. X linked neonatal centronuclear/myotubular myopathy: evidence for linkage to Xq28 DNA marker loci. J Med Genet. 1990 May;27(5):284–287. doi: 10.1136/jmg.27.5.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tommerup N. Mendelian cytogenetics. Chromosome rearrangements associated with mendelian disorders. J Med Genet. 1993 Sep;30(9):713–727. doi: 10.1136/jmg.30.9.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Vincent A., Kretz C., Oberlé I., Mandel J. L. A new polymorphic marker very closely linked to DXS52 in the q28 region of the human X chromosome. Hum Genet. 1989 Apr;82(1):85–86. doi: 10.1007/BF00288280. [DOI] [PubMed] [Google Scholar]
  36. Wallgren-Pettersson C., Thomas N. S. Report on the 20th ENMC sponsored international workshop: myotubular/centronuclear myopathy. Neuromuscul Disord. 1994 Jan;4(1):71–74. doi: 10.1016/0960-8966(94)90050-7. [DOI] [PubMed] [Google Scholar]
  37. Wasteson A., Neufeld E. F. Iduronate sulfatase from human plasma. Methods Enzymol. 1982;83:573–578. doi: 10.1016/0076-6879(82)83053-x. [DOI] [PubMed] [Google Scholar]
  38. Weber C., Oudet C., Johnson S., Pilia G., Schlessinger D., Hanauer A. Dinucleotide repeat polymorphism close to IDS gene in Xq27.3-q28 (DXS1113). Hum Mol Genet. 1993 May;2(5):612–612. doi: 10.1093/hmg/2.5.612-a. [DOI] [PubMed] [Google Scholar]
  39. Wilson P. J., Morris C. P., Anson D. S., Occhiodoro T., Bielicki J., Clements P. R., Hopwood J. J. Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8531–8535. doi: 10.1073/pnas.87.21.8531. [DOI] [PMC free article] [PubMed] [Google Scholar]